Noile-Immune Biotech Inc. (4893.T)
JPY 163.0
(-1.81%)
JPY 163.0
(-1.81%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 316.81 Million JPY | -49.37% |
| 2022 | 625.78 Million JPY | 521.24% |
| 2021 | 100.73 Million JPY | 3.55% |
| 2020 | 97.27 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.58 Million JPY | -3.25% |
| 2024 Q2 | - JPY | -100.0% |
| 2023 Q4 | 2.67 Million JPY | -99.12% |
| 2023 Q3 | 302.8 Million JPY | 9237.03% |
| 2023 FY | 316.81 Million JPY | -49.37% |
| 2023 Q1 | 8.1 Million JPY | 62.02% |
| 2023 Q2 | 3.24 Million JPY | -59.97% |
| 2022 Q4 | 5 Million JPY | 0.0% |
| 2022 FY | 625.78 Million JPY | 521.24% |
| 2021 FY | 100.73 Million JPY | 3.55% |
| 2020 FY | 97.27 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 93.358% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -180.554% |
| GNI Group Ltd. | 26.01 Billion JPY | 98.782% |
| Linical Co., Ltd. | 12.3 Billion JPY | 97.426% |
| Trans Genic Inc. | 13.08 Billion JPY | 97.578% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 52.109% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 93.858% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 79.696% |
| AnGes, Inc. | 152.98 Million JPY | -107.091% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 48.073% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 97.518% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 61.208% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -133.8% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 80.514% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 26.04% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 83.336% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 53.577% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 86.969% |
| PeptiDream Inc. | 28.71 Billion JPY | 98.897% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -402.583% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -161.833% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -439925.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -694.289% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 92.976% |
| FunPep Company Limited | 530 Thousand JPY | -59676.981% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -357.499% |
| Stella Pharma Corporation | 269.49 Million JPY | -17.562% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Cuorips Inc. | 23.1 Million JPY | -1271.388% |
| K Pharma,Inc. | 1 Billion JPY | 68.318% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.272% |
| ReproCELL Incorporated | 2.42 Billion JPY | 86.945% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 81.53% |
| StemCell Institute Inc. | 2.48 Billion JPY | 87.231% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 87.399% |
| CellSeed Inc. | 190.13 Million JPY | -66.629% |